Researchers analyzed data from 22 studies involving 4,186 individuals to identify microRNAs (miRNAs) that change in Alzheimer's disease. They found 2,895 miRNAs that were consistently detected across studies. Among these, 194 showed widespread changes in Alzheimer's disease, including some not previously linked to the condition.
The altered miRNAs are involved in biological pathways outside the brain, such as interleukin signaling, Toll receptor signaling, the p38 MAPK pathway, and the insulin/IGF pathway. These pathways are related to inflammation and metabolism, suggesting that Alzheimer's disease affects systems beyond the central nervous system.
This meta-analysis provides a comprehensive list of miRNAs that could serve as next-generation biomarkers for Alzheimer's disease. The findings may also help design therapies that target these miRNAs. However, the study does not prove that these miRNAs cause Alzheimer's disease; it only shows an association. More research is needed to confirm their role and potential as treatment targets.
Common questions
What are microRNAs and why do they matter in Alzheimer's?
MicroRNAs (miRNAs) are small molecules that help control how our genes work. This study looked at these molecules to see which ones change when a person has Alzheimer's disease. By identifying 194 specific miRNAs that show widespread changes, researchers hope to find better ways to track the disease and develop new treatments.
How many different microRNAs were found in this study?
The analysis identified a total of 2,895 reproducibly identified miRNAs. From that large group, researchers narrowed it down to 194 miRNAs that showed widespread changes in Alzheimer's disease. Some of these 194 were new and had not been linked to the disease before.
What biological pathways are these microRNAs involved in?
The study found that these microRNAs influence several important pathways outside of the brain. These include interleukin signaling, Toll receptor signaling, the p38 MAPK pathway, and the insulin/IGF pathway. These findings help researchers understand how the disease affects different parts of the body.
